Meropenem Exposure During Extracorporeal Membrane Oxygenation: What Should Intensivists Know? A Scoping Review
Journal of Intensive Care Medicine · 01.08.2026
DOI: 10.1177/08850666261469109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 01.08.2026. Verfasst von Jonathan Camilo Ramirez und 7 weiteren Autor:innen. Beteiligte Einrichtung: PGY-3 at the Clinical Pharmacology Department, Faculty of Medicine, Universidad de La Sabana, Chía, Colombia. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universidad de La Sabana.
Abstract (Originalsprache)
Background
Extracorporeal membrane oxygenation (ECMO) is increasingly used in adults with severe respiratory and/or cardiac failure. Because ECMO may alter drug pharmacokinetics (PK), optimizing antimicrobial dosing in this population remains challenging. Meropenem is widely administered in intensive care units (ICUs), yet its disposition during ECMO is not fully understood. This scoping review aimed to characterize population PK methodologies and synthesize current evidence on meropenem pharmacokinetics and pharmacodynamics (PK/PD) in critically ill adults receiving ECMO.
Methods
A scoping review was conducted according to PRISMA-ScR guidelines. Studies reporting population PK and/or PD data for meropenem in adult ICU patients undergoing ECMO were included. Systematic searches were performed in Embase, PubMed, LILACS, ProQuest, Web of Science, and Scopus for publications between January 1, 2012, and December 31, 2022. Two independent reviewers screened and selected eligible studies.
Results
Eleven studies, including observational cohorts, case series, and simulation-based analyses, met inclusion criteria. Across studies, glomerular filtration rate (GFR) and renal replacement therapy (RRT) were the principal determinants of meropenem clearance, whereas ECMO had a comparatively limited direct effect. Although ECMO may transiently increase volume of distribution and promote early drug sequestration within the circuit, these effects were generally outweighed by renal function parameters. Standard dosing regimens frequently failed to achieve pharmacodynamic targets (fT > MIC ≥40–100%), particularly in patients with augmented renal clearance (ARC). Prolonged or continuous infusions combined with therapeutic drug monitoring (TDM) were consistently associated with improved target attainment.
Conclusions
In ECMO-supported critically ill adults, meropenem exposure is driven predominantly by residual renal function, RRT, and ARC rather than ECMO itself. Individualized dosing strategies incorporating PK modeling and TDM are essential to optimize therapy. Prospective, standardized studies are needed to refine dosing recommendations in this complex population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PGY-3 at the Clinical Pharmacology Department, Faculty of Medicine, Universidad de La Sabana, Chía, Colombia.
- These authors contributed equally to this work.
- Faculty of Medicine, Universidad de La Sabana, Chía, Colombia.
- Critical Care Service, Fundación Clínica Shaio, Bogotá, Colombia.
- Department of Pharmacology, Evidence-Based Therapeutics Group, Faculty of Medicine, Universidad de La Sabana and Clínica Universidad de La Sabana, Chía, Colombia.
ORCID-Profile: Sergio Fabian Rodriguez, Alirio Bastidas, Rosa Helena Bustos Cruz
Förderung
- Universidad de La Sabana
Zitieren
APA
Ramirez, J. C., Rodriguez, S. F., Bastidas, A., Vargas, D., Guevara, J. F., Poveda-Henao, C., Mercado, M., & Bustos Cruz, R. H. (2026). Meropenem Exposure During Extracorporeal Membrane Oxygenation: What Should Intensivists Know? A Scoping Review. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666261469109
Vancouver
Ramirez JC, Rodriguez SF, Bastidas A, Vargas D, Guevara JF, Poveda-Henao C, et al. Meropenem Exposure During Extracorporeal Membrane Oxygenation: What Should Intensivists Know? A Scoping Review. Journal of Intensive Care Medicine. 2026. doi:10.1177/08850666261469109
BibTeX
@article{Ramirez2026,
author = {Ramirez, Jonathan Camilo and Rodriguez, Sergio Fabian and Bastidas, Alirio and Vargas, Daniela and Guevara, Juan-Francisco and Poveda-Henao, Claudia and Mercado, Mario and Bustos Cruz, Rosa Helena},
title = {Meropenem Exposure During Extracorporeal Membrane Oxygenation: What Should Intensivists Know? A Scoping Review},
journal = {Journal of Intensive Care Medicine},
year = {2026},
doi = {10.1177/08850666261469109}
}
EUVIMED